200,000+ products from a single source!
sales@angenechem.com
Home > Indoles and Oxindole > 101246-66-6
101246-66-6 | Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, 5-(N-phenylcarbamate), (3aS,8aR)-
CAS No: 101246-66-6 Catalog No: AG00041U MDL No:
Product Description
Catalog Number:
AG00041U
Chemical Name:
Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, 5-(N-phenylcarbamate), (3aS,8aR)-
CAS Number:
101246-66-6
Molecular Formula:
C20H23N3O2
Molecular Weight:
337.4155
IUPAC Name:
[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-phenylcarbamate
InChI:
InChI=1S/C20H23N3O2/c1-20-11-12-22(2)18(20)23(3)17-10-9-15(13-16(17)20)25-19(24)21-14-7-5-4-6-8-14/h4-10,13,18H,11-12H2,1-3H3,(H,21,24)/t18-,20+/m1/s1
InChI Key:
PBHFNBQPZCRWQP-QUCCMNQESA-N
SMILES:
O=C(Nc1ccccc1)Oc1ccc2c(c1)[C@]1(C)CCN([C@@H]1N2C)C
UNII:
SUE285UG3S
Properties
Complexity:
507
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
2
Defined Bond Stereocenter Count:
0
Exact Mass:
337.179g/mol
Formal Charge:
0
Heavy Atom Count:
25
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
337.423g/mol
Monoisotopic Mass:
337.179g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
44.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.3
Literature
| Title | Journal |
|---|---|
| Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans. | Journal of neurology, neurosurgery, and psychiatry 20120901 |
| Acetylcholinesterase deficiency contributes to neuromuscular junction dysfunction in type 1 diabetic neuropathy. | American journal of physiology. Endocrinology and metabolism 20120815 |
| Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities. | Bioorganic & medicinal chemistry 20120815 |
| Synthesis of (+)-phenserine using an interrupted Fischer indolization reaction. | The Journal of organic chemistry 20120106 |
| Acetylcholinesterase inhibition ameliorates deficits in motivational drive. | Behavioral and brain functions : BBF 20120101 |
| Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model. | Brain research 20111202 |
| Molybdenum-catalyzed asymmetric allylic alkylation of 3-alkyloxindoles: reaction development and applications. | Chemistry (Weinheim an der Bergstrasse, Germany) 20110301 |
| Cholinesterase inhibitors improve both memory and complex learning in aged beagle dogs. | Journal of Alzheimer's disease : JAD 20110101 |
| Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology. | Journal of medicinal chemistry 20100909 |
| Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities. | Bioorganic & medicinal chemistry letters 20100301 |
| Phenserine efficacy in Alzheimer's disease. | Journal of Alzheimer's disease : JAD 20100101 |
| Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors. | Bioorganic & medicinal chemistry letters 20091201 |
| The perils of Alzheimer's drug development. | Current Alzheimer research 20090201 |
| Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions. | The Biochemical journal 20090101 |
| How to approach Alzheimer's disease therapy using stem cell technologies. | Journal of Alzheimer's disease : JAD 20081001 |
| Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. | Annals of neurology 20080501 |
| Phenserine. | Expert opinion on investigational drugs 20070701 |
| Preclinical investigation of the topical administration of phenserine: transdermal flux, cholinesterase inhibition, and cognitive efficacy. | The Journal of pharmacology and experimental therapeutics 20070401 |
| Total synthesis of (+/-) -phenserine via [4+1] cyclization of a bis(alkylthio)carbene and an indole isocyanate. | Organic letters 20070329 |
| The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice. | The Journal of pharmacology and experimental therapeutics 20070101 |
| Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease. | Neuromolecular medicine 20070101 |
| Kinetics of human serum butyrylcholinesterase and its inhibition by a novel experimental Alzheimer therapeutic, bisnorcymserine. | Journal of Alzheimer's disease : JAD 20060901 |
| Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptide. | The Journal of pharmacology and experimental therapeutics 20060801 |
| Palladium-catalyzed enantioselective C-3 allylation of 3-substituted-1H-indoles using trialkylboranes. | Journal of the American Chemical Society 20060517 |
| Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease. | Expert opinion on investigational drugs 20060101 |
| Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects. | Current Alzheimer research 20051001 |
| An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. | Current Alzheimer research 20050701 |
| Phenserine Axonyx. | Current opinion in investigational drugs (London, England : 2000) 20050701 |
| Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging. | Progress in neuro-psychopharmacology & biological psychiatry 20050301 |
| Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine. | Journal of medicinal chemistry 20050224 |
| The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats. | Life sciences 20050121 |
| The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region. | Annals of the New York Academy of Sciences 20041201 |
| Asymmetric synthesis of pyrrolidinoindolines. Application for the practical total synthesis of (-)-phenserine. | Journal of the American Chemical Society 20041103 |
| Sensitivity of [11C]N-methylpyrrolidinyl benzilate ([11C]NMPYB) to endogenous acetylcholine: PET imaging vs tissue sampling methods. | Nuclear medicine and biology 20040501 |
| (R)-N-[11C]methyl-3-pyrrolidyl benzilate, a high-affinity reversible radioligand for PET studies of the muscarinic acetylcholine receptor. | Synapse (New York, N.Y.) 20020701 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action. | Journal of medicinal chemistry 20011122 |
| Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20010201 |
| Phenserine (Axonyx/NIH). | IDrugs : the investigational drugs journal 20001001 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.